Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Nolan

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Australian and New Zealand Journal of Public Health|August 19, 2021
National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012-2015Lisa McHugh, Kerry-Ann F O'Grady, Terry Nolan, et al.
Vaccines|February 28, 2023
Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare BudgetRitika Kapoor, Baudouin Standaert, Edmund J Pezalla, et al.
Vaccines|July 27, 2024
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key ConceptsEliana Biundo, Mariia Dronova, Annie Chicoye, et al.
Human Vaccines & Immunotherapeutics|July 17, 2024
Public health management of pertussis in adults: Practical challenges and future strategiesC Raina MacIntyre, Jaime Correia de Sousa, Ulrich Heininger, et al.
Human Vaccines & Immunotherapeutics|April 2, 2024
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendationsPeter Kardos, Jaime Correia de Sousa, Ulrich Heininger, et al.
Lancet (London, England)|December 1, 2018
Australian health professionals' statement on climate change and healthKerry Arabena, Fiona Armstrong, Helen Berry, et al.
Open Forum Infectious Diseases|November 25, 2024
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young AdultsTerry Nolan, Chiranjiwi Bhusal, Jiří Beran, et al.
The Lancet. Infectious Diseases|December 8, 2024
Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trialTerry Nolan, Chiranjiwi Bhusal, Jiří Beran, et al.
Vaccine|October 12, 2021
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind studyCorinne Vandermeulen, Isabel Leroux-Roels, James Vandeleur, et al.
Vaccine|September 6, 2016
Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trialWilliam J H Mcbride, Walter P Abhayaratna, Ian Barr, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Australian and New Zealand Journal of Public Health|August 19, 2021
National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012-2015Lisa McHugh, Kerry-Ann F O'Grady, Terry Nolan, et al.
Vaccines|February 28, 2023
Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare BudgetRitika Kapoor, Baudouin Standaert, Edmund J Pezalla, et al.
Vaccines|July 27, 2024
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key ConceptsEliana Biundo, Mariia Dronova, Annie Chicoye, et al.
Human Vaccines & Immunotherapeutics|July 17, 2024
Public health management of pertussis in adults: Practical challenges and future strategiesC Raina MacIntyre, Jaime Correia de Sousa, Ulrich Heininger, et al.
Human Vaccines & Immunotherapeutics|April 2, 2024
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendationsPeter Kardos, Jaime Correia de Sousa, Ulrich Heininger, et al.
Lancet (London, England)|December 1, 2018
Australian health professionals' statement on climate change and healthKerry Arabena, Fiona Armstrong, Helen Berry, et al.
Open Forum Infectious Diseases|November 25, 2024
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young AdultsTerry Nolan, Chiranjiwi Bhusal, Jiří Beran, et al.
The Lancet. Infectious Diseases|December 8, 2024
Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trialTerry Nolan, Chiranjiwi Bhusal, Jiří Beran, et al.
Vaccine|October 12, 2021
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind studyCorinne Vandermeulen, Isabel Leroux-Roels, James Vandeleur, et al.
Vaccine|September 6, 2016
Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trialWilliam J H Mcbride, Walter P Abhayaratna, Ian Barr, et al.
Pageof 10